Sarepta Therapeutics SRPT
NASDAQ SRPT
$22.50 -0.49 (-2.13%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sarepta Therapeutics (SRPT) Tax Rate Growth (3y) (2020 - 2026)

Analysis

Sarepta Therapeutics (SRPT) Tax Rate Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sarepta Therapeutics 2.36 Bn 1.57 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,514.00
Mar 31, 2026 435.00
Dec 31, 2025 667.00
Sep 30, 2025 778.00
Jun 30, 2025 -2,670.00
Mar 31, 2025 -1,584.00
Dec 31, 2024 761.00
Sep 30, 2024 167.00
Jun 30, 2024 5,199.00
Mar 31, 2024 1,277.00
Dec 31, 2023 -1,233.00
Sep 30, 2023 -2,346.00
Jun 30, 2023 -6,444.00
Mar 31, 2023 -13.00
Dec 31, 2022 -814.00
Sep 30, 2022 -34.00
Jun 30, 2022 -142.00
Mar 31, 2022 -73.00
Dec 31, 2021 -63.00
Sep 30, 2021 -137.00